Learn more Got it! United in sending patients home, disease free We all know someone coping with illness. Maybe we've known her our whole lives. Maybe we haven't met him yet. Maybe they're us. WE DO THIS WORK FOR ALL OF US Here's how WE are making a difference Each day we come into work focused on one thing: advancing potential treatments for patients in need. Today, patients all over the world are participating in our clinical studies. EXPLORE PROGRAMS Biliary Tract Cancer Biliary tract cancers are rare tumors that affect the bile ducts inside and outside the liver (cholangiocarcioma) or the gall bladder (gall bladder cancer). 2 clinical trials Breast Cancer Breast cancer occurs when cells of the breast grow uncontrollably. 3 clinical trials Gastroesophageal Adenocarcinomas Gastroesophageal adenocarcinomas (GEAs) are cancers that begin in the stomach (gastric) and gastroesophageal junction. 2 clinical trials Other Cancers Other types of cancers also express too much human epidermal growth factor receptor 2, or HER2, a protein normally involved in cell growth. 2 clinical trials LEARN ABOUT CLINICAL TRIALS Clinical trials are scientific studies, conducted by doctors, to determine how well a new treatment works and if it has any side eﬀects in people. The goal is to help people by finding better ways to prevent, screen for, diagnose, or treat disease. People can participate in clinical trials as patients or healthy volunteers1. Clinical trials are the final step in a long process, which typically takes over a decade and begins with discoveries made in a research laboratory2. All approved medicines have been tested in clinical trials and are regulated by health authorities, such as the Food and Drug Administration (FDA) and European Medical Agency (EMA). To participate in a clinical trial, please contact your doctor. For more information about clinical trials, visit the National Institutes for Health Clinical Trials website. 1FDA - Clinical Research Versus Medical Treatment 2FDA - Learn About Drug and Device Approvals OUR EXPANDED ACCESS POLICY TECHNOLOGY Azymetric™ ZymeLink™ EFECT™ ProTECT™ Science PIPELINE Zanidatamab ZW49 Preclinical Candidates Partnerships Publications For Patients INVESTORS Stock Info News Releases Events & Presentations Financials Governance CORPORATE Leadership Board of Directors Careers Legal Privacy Contact Twitter LinkedIn